ArticleMedicine2026
Association between dietary thiamine intake and serum lipid profiles in U.S. adults: NHANES 2021-2023.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thiamine (vitamin B1) is an essential water-soluble vitamin involved in carbohydrate metabolism and energy production. Emerging evidence suggests that thiamin may influence lipid metabolism and cardiovascular risk, yet population-based data are limited and inconsistent. This study aimed to investigate the association between dietary thiamin intake and serum lipid profiles, including total cholesterol, LDL-C, HDL-C, and triglycerides, among U.S. adults. Data from 4986 fasting adults aged ≥ 18 years from the National Health and Nutrition Examination Survey (NHANES) 2021 to 2023 were analyzed. Dietary thiamin intake was assessed using the first 24-hour dietary recall and classified into four intake categories based on the distribution of thiamin intake. Linear regression models were used to examine the associations between dietary thiamin intake and serum lipid components, with sequential adjustment for demographic, socioeconomic, lifestyle, dietary, and health-related factors. A sensitivity analysis was additionally performed, adjusting for lipid-lowering medication use. In fully adjusted models, higher thiamin intake was associated with lower total cholesterol (β = -7.13, SE = 2.61, P = .007) and LDL-C (β = -6.72, SE = 3.27, P = .04). No significant associations were observed with HDL-C (β = -0.21, SE = 0.80, P = .79) or triglycerides (β = 13.82, SE = 10.37, P = .183). In the sensitivity analysis additionally adjusted for lipid-lowering medication use, the associations with total cholesterol and LDL-C remained significant, while those with HDL-C and triglycerides remained nonsignificant. These findings indicate an inverse association between dietary thiamin intake and selected atherogenic lipid fractions. Among U.S. adults, higher dietary thiamin intake is associated with lower total and LDL cholesterol levels. Higher thiamin intake may be associated with a more favorable lipid profile and may represent a potential dietary factor relevant to cardiovascular risk management. Given the cross-sectional design, causal relationships cannot be inferred, and further prospective and interventional studies are warranted to confirm these findings and elucidate underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.